EUVIMEDEUVIMED entdecken
Open Access

Lesion Volume Divided by ADC Measures Is an Independent Prognostic Marker in Colorectal Liver Metastasis Treated by Y90-radioembolization

Franziska Heitmann, Sebastian M Christ, Christine March, Maciej Pech, Maximilian Thormann, Robert Damm

In Vivo · 2025

DOI: 10.21873/invivo.13827 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Franziska Heitmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, University of Magdeburg, Magdeburg, Germany. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Yttrium Radioisotopes, Tumor Burden. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: To assess the ability of apparent diffusion coefficient (ADC) at baseline in predicting overall survival in patients who undergo Y90-radioembolization (Y90-RE) for liver-dominant metastatic colorectal cancer (mCRC) in the salvage situation. PATIENTS AND METHODS: A retrospective review of 411 lesions in 63 patients with refractory mCRC treated with Y90-RE was conducted. Manual region of interest (ROI) measurements were applied using a whole lesion and volume method. Minimum and mean ADC values were measured, and averages were calculated per patient. Ratios combining tumor volume and ADC were correlated with OS, and a receiver-operating characteristic (ROC) analysis defined a cut-off value. Cox regression analysis was performed, and the log-rank test confirmed prognostic cut-off levels for survival. RESULTS: The median survival was 6.4 months. Multivariate Cox regression identified tumor volume divided by minimum ADC (ADCtumor volume, min) as an independent predictor of OS (HR=1.814, 95%CI=1.188-2.770, p=0.006). Neither ADCmin nor ADCmean were significantly associated with survival. Optimal prediction was identified with a ADCtumor volume, min cut-off of 0.3673 arbitrary units (AU) yielding 76.0% sensitivity and 70.3% specificity. Patients with ADCtumor volume min

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsLiver NeoplasmsYttrium RadioisotopesTumor BurdenEmbolization, TherapeuticHumansMaleFemalePrognosisAgedMiddle AgedAged, 80 and overAdultROC CurveRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

Diffusion-weighted MRIapparent diffusion coefficientcolorectal carcinomaradioembolization

Substanzen

Yttrium RadioisotopesYttrium-90

Autor:innen und Institutionen

  • Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, University of Magdeburg, Magdeburg, Germany.
  • Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Department of Radiation Oncology, Charité Berlin, Berlin, Germany.
  • Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, University of Magdeburg, Magdeburg, Germany; maximilian.thormann@med.ovgu.de.
  • Department of Nuclear Medicine, Charité Berlin, Berlin, Germany.
  • Practice of Radiology, Dessau, Germany.

Zitieren

APA

Heitmann, F., Christ, S. M., March, C., Pech, M., Thormann, M., & Damm, R. (2025). Lesion Volume Divided by ADC Measures Is an Independent Prognostic Marker in Colorectal Liver Metastasis Treated by Y90-radioembolization. In Vivo. https://doi.org/10.21873/invivo.13827

Vancouver

Heitmann F, Christ SM, March C, Pech M, Thormann M, Damm R. Lesion Volume Divided by ADC Measures Is an Independent Prognostic Marker in Colorectal Liver Metastasis Treated by Y90-radioembolization. In Vivo. 2025. doi:10.21873/invivo.13827

BibTeX
@article{Heitmann2025,
  author = {Heitmann, Franziska and Christ, Sebastian M and March, Christine and Pech, Maciej and Thormann, Maximilian and Damm, Robert},
  title = {Lesion Volume Divided by ADC Measures Is an Independent Prognostic Marker in Colorectal Liver Metastasis Treated by Y90-radioembolization},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.13827}
}
Kostenlos starten →